• Consensus Rating: Moderate Buy
  • Consensus Price Target: $27.25
  • Forecasted Upside: 144.83%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$11.13
▲ +0.24 (2.20%)

This chart shows the closing price for MODV by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New ModivCare Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MODV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MODV

Analyst Price Target is $27.25
▲ +144.83% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for ModivCare in the last 3 months. The average price target is $27.25, with a high forecast of $40.00 and a low forecast of $14.00. The average price target represents a 144.83% upside from the last price of $11.13.

This chart shows the closing price for MODV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 4 contributing investment analysts is to moderate buy stock in ModivCare. This rating has held steady since July 2024, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/29/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/27/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/26/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/25/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/23/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/21/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
11/20/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
12/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/18/2024Barrington ResearchReiterated RatingOutperform ➝ Outperform$25.00 ➝ $25.00
11/8/2024Barrington ResearchBoost TargetOutperform ➝ Outperform$22.00 ➝ $25.00
10/3/2024Barrington ResearchBoost TargetOutperform ➝ Outperform$19.00 ➝ $22.00
9/17/2024Barrington ResearchLower TargetOutperform ➝ Outperform$35.00 ➝ $19.00
9/17/2024Lake Street CapitalLower TargetBuy ➝ Buy$50.00 ➝ $30.00
9/13/2024Jefferies Financial GroupLower TargetHold ➝ Hold$25.00 ➝ $14.00
8/9/2024Barrington ResearchUpgradeMarket Perform ➝ Outperform$35.00
5/6/2024Lake Street CapitalUpgradeHold ➝ Buy$50.00
2/26/2024Barrington ResearchDowngradeOutperform ➝ Market Perform
2/23/2024Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold$60.00 ➝ $40.00
2/23/2024Jefferies Financial GroupDowngradeBuy ➝ Hold$60.00 ➝ $39.00
11/6/2023Barrington ResearchBoost TargetOutperform ➝ Outperform$58.00 ➝ $68.00
8/7/2023Deutsche Bank AktiengesellschaftLower TargetBuy ➝ Buy$75.00 ➝ $50.00
8/7/2023Barrington ResearchLower TargetOutperform ➝ Outperform$92.00 ➝ $58.00
5/5/2023Deutsche Bank AktiengesellschaftLower Target$120.00 ➝ $75.00
5/5/2023StephensLower Target$145.00 ➝ $95.00
5/5/2023Barrington ResearchLower Target$143.00 ➝ $92.00
2/24/2023Barrington ResearchBoost TargetOutperform$138.00 ➝ $143.00
2/24/2023Deutsche Bank AktiengesellschaftBoost TargetBuy$100.00 ➝ $120.00
11/4/2022Barrington ResearchLower TargetOutperform$157.00 ➝ $138.00
8/9/2022Barrington ResearchBoost Target$157.00
8/3/2022StephensReiterated RatingInitiates
8/2/2022StephensInitiated CoverageOverweight$145.00
5/6/2022Deutsche Bank AktiengesellschaftLower Target$150.00 ➝ $130.00
2/28/2022Barrington ResearchLower TargetOutperform$190.00 ➝ $155.00
2/3/2022Deutsche Bank AktiengesellschaftLower TargetBuy$180.00 ➝ $150.00
12/17/2021Deutsche Bank AktiengesellschaftInitiated CoverageBuy$180.00
8/4/2021Barrington ResearchBoost TargetOutperform$170.00 ➝ $186.00
7/27/2021Barrington ResearchReiterated RatingBuy$170.00
5/10/2021Barrington ResearchBoost TargetOutperform$162.00 ➝ $170.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

1.17 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
5/25/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/24/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/24/2024
  • 3 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/23/2024
  • 4 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/22/2024
  • 8 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/22/2024
  • 11 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
11/21/2024
  • 8 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/21/2024

Current Sentiment

  • 8 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
ModivCare logo
ModivCare Inc., a technology-enabled healthcare services company, provides a suite of integrated supportive care solutions for public and private payors and their members. The company operates through four segments: Non-Emergency Medical Transportation (NEMT), Personal Care, Remote Patient Monitoring (RPM), and Corporate and Other. The company offers risk underwriting, contact center management, network credentialing, claims management, and non-emergency medical transport management services for Medicaid or Medicare eligible members, whose limited mobility or financial resources hinder their ability to access necessary healthcare and social services. It also provides in-home personal care services, such as bathing, personal hygiene, grooming, oral care, dressing, medication reminders, meal planning, preparation and feeding, housekeeping, transportation services, prescription reminders, and assistance with dressing and ambulation services through placing non-medical personal care assistants, home health aides, and skilled nurses primarily to Medicaid patients in need of care monitoring and assistance in performing daily living activities, including senior citizens and disabled adults. In addition, the company offers remote patient monitoring solutions, including personal emergency response systems, vitals monitoring, medication management, and data-driven patient engagement solutions. It serves federal, state, and local government agencies, MCOs, commercial insurers, private individuals, and health systems. The company was formerly known as The Providence Service Corporation and changed its name to ModivCare Inc. in January 2021. ModivCare Inc. was incorporated in 1996 and is headquartered in Denver, Colorado.
Read More

Today's Range

Now: $11.13
Low: $10.63
High: $11.66

50 Day Range

MA: $16.34
Low: $10.89
High: $18.81

52 Week Range

Now: $11.13
Low: $10.63
High: $52.33

Volume

521,656 shs

Average Volume

251,897 shs

Market Capitalization

$158.98 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.52

Frequently Asked Questions

What sell-side analysts currently cover shares of ModivCare?

The following Wall Street analysts have issued stock ratings on ModivCare in the last twelve months: Barrington Research, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., and Lake Street Capital.
View the latest analyst ratings for MODV.

What is the current price target for ModivCare?

0 Wall Street analysts have set twelve-month price targets for ModivCare in the last year. Their average twelve-month price target is $27.25, suggesting a possible upside of 144.8%. Deutsche Bank Aktiengesellschaft has the highest price target set, predicting MODV will reach $40.00 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of $14.00 for ModivCare in the next year.
View the latest price targets for MODV.

What is the current consensus analyst rating for ModivCare?

ModivCare currently has 2 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for MODV.

What other companies compete with ModivCare?

How do I contact ModivCare's investor relations team?

ModivCare's physical mailing address is 1275 Peachtree Street Sixth Floor, Atlanta GA, 30309. The company's listed phone number is (303) 728-7030 and its investor relations email address is [email protected]. The official website for ModivCare is www.modivcare.com. Learn More about contacing ModivCare investor relations.